19Feb/19

Statement from FDA Commissioner Scott Gottlieb, MD, and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, MD, Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions – FDA.gov

Statement from FDA Commissioner Scott Gottlieb, MD, and Director of FDA’s Center for Biologics Evaluation and Research Peter Marks, MD, Ph.D., cautioning consumers against receiving young donor plasma infusions that are promoted as unproven treatment for varying conditions  FDA.gov

Español. The FDA has recently become aware of reports of establishments in several states that are offering infusions of plasma from young donors to …